Recent Press Releases

AMRI Updates 2015 Financial Guidance Following Gadea Acquisition

ALBANY, N.Y. -- Following the acquisition of Gadea Pharmaceutical Group, AMRI (NASDAQ: AMRI) has updated guidance for full year 2015. "We are very pleased to provide our updated outlook for 2015...

WuXi NextCODE and Fudan Children's Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China

SHANGHAI and CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Sept. 16, 2015 /PRNewswire/ -- WuXi NextCODE, a precision medicine company using the genome to improve health worldwide, and the Children's...

goBalto joins Society for Clinical Research Sites as Global Impact Partner

SAN FRANCISCO -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today a two-year partnership with the Society for Clinical Research Sites (SCRS), the...

Bio-specimen Grant Program Launches

MINNEAPOLIS -- DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its...

Walvax Biotechnology Selects Medidata's Cloud-Based Platform to Advance Pediatric Vaccine Program in China

NEW YORK--()--Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its industry-leading technology...

Aragen Bioscience Announces Licensing Agreement for Protein Production Technology from ProteoNic Biotechnology

Morgan Hill, Ca, US -- Aragen Bioscience, Inc. (Aragen) announces that it has entered into an agreement with ProteoNic Biotechnology BV (ProteoNic) for the commercial use of ProteoNic's 2G...

RHO AWARDED NEW FEDERAL COOPERATIVE AGREEMENT FROM NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

CRO embarks on the company's largest-ever federal project Chapel Hill, NC (September 9, 2015) – Rho, a contract research organization (CRO) providing clinical research services in both the...

ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines

ICON applies IBM Watson Clinical Trial Matching to Oncology Clinical Trials Dublin, Ireland, 10 September, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and...

Aragen Bioscience Announces Licensing Agreement for Protein Production Technology from ProteoNic Biotechnology

Aragen Bioscience Announces Licensing Agreement for Protein Production Technology from ProteoNic Biotechnology Morgan Hill, Ca, US, September 9, 2015 / B3C newswire / -- Aragen Bioscience, Inc....

Medidata and Japan Pharmaceutical Manufacturers Association Collaborate on New Research Aimed at Streamlining Clinical Trial Costs Across Japan

NEW YORK--()--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced a research collaboration with the Japan...

Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials

DAVIS, Calif. -- Mytrus, a technology and services company revolutionizing clinical trials, announced today that its software platform for electronic informed consent has received approval for use by...

PPD Collaborates with CISYS LifeSciences to Implement New Web-based Event Adjudication System

WILMINGTON, N.C. & RALEIGH, N.C.--()--Pharmaceutical Product Development, LLC (PPD) and CISYS LifeSciences today announced PPD's implementation of Sequence WebEAS, a new...

WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device...

Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc.

OKLAHOMA CITY, OK--(Marketwired) - Cytovance® Biologics, Inc., announced today that they have entered into a definitive agreement by which Hepalink USA Inc. will acquire Cytovance® Biologics...

AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived...

PAREXEL Names Maykin Ho to Board of Directors

BOSTON, Aug. 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors have elected...

TxCell Consortium Granted €1.28 million for TRUST Project on Process and Clinical Development of Col-Treg for Autoimmune Uveitis Treatment

French Government and local authorities award grant from the Unique Interministerial Fund (FUI) to the consortium composed of TxCell, Provepep, Hospital La Pitié Salpêtrière...

INC Research Enhances Therapeutic Expertise with Key Promotions in General Medicine and CNS

Industry leaders to drive innovation across key clinical research areas RALEIGH, N.C., Aug. 25, 2015 – INC Research Holdings, Inc. (Nasdaq: INCR), a leading, global Phase I to IV contract...

WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm

SHANGHAI, Aug. 25, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. WX, -1.02% a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology,...

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection 26 August 2015: Recipharm AB, Stockholm, today announces that it has signed an...